Toronto Dominion Bank - Sep 30, 2025 SCHEDULE 13G Report for Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK)

Filing Manager: TORONTO DOMINION BANK
Reporting Manager: The Toronto-Dominion Bank
Security: Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: STOK
Shares outstanding: 54.7M shares
Disclosed Ownership: 3.17M shares
Ownership: 5.8%
Form type: SCHEDULE 13G
Date filed: 11/14/2025, 11:24 AM
Date of event: Sep 30, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Toronto-Dominion Bank	5.8%	3.17M	3.17M	0	Christina Petrou	Christina Petrou / Executive Vice President & Chief Operating Officer